85. It would be appropriate to report a medication error in the event that a pharmacy substituted:
Answer: C
Clonidine for Klonopin should be reported as a medication error.
Substituting Clonidine for Klonopin represents a significant medication error, as these two drugs have different indications, mechanisms of action, and potential side effects, which could lead to serious patient safety issues.
A) Celecoxib for Celebrex
Celecoxib is the generic name for Celebrex; therefore, substituting one for the other is not a medication error. They are the same medication, and this substitution would not pose any risk of confusion or harm to the patient.
B) Bumetanide for Bumex
Bumetanide is the generic name for Bumex, making this substitution correct and not a medication error. There is no safety concern involved, as they refer to the same drug, thus ensuring consistent treatment.
C) Clonidine for Klonopin
Clonidine and Klonopin (Clonazepam) are completely different medications with distinct uses; Clonidine is primarily used for hypertension, while Klonopin is an anticonvulsant and anxiolytic. This substitution could lead to severe health consequences, justifying its classification as a medication error.
D) Valacyclovir for Valtrex
Valacyclovir is the generic name for Valtrex, which means substituting one for the other does not constitute a medication error. This is a standard practice in pharmacy as both names refer to the same effective antiviral medication.
Conclusion
The only substitution that should be reported as a medication error is Clonidine for Klonopin due to the critical differences in their therapeutic uses and the potential for serious adverse effects. All other options involve generic and brand name equivalents, which are acceptable and safe substitutions in pharmacy practice.